$1.54
+0.01 (+0.65%)
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,170.8% upside
Low Target
$11.03
Average Target
$19.57
High Target
$23.80
Current Price
$1.54
Current
$1.54
$1.54
Target
$19.57
$19.57
$11.03
$19.57 avg
$23.80
Scenario Analysis
Bear Case
$11.03
616.2%
Low target
Base Case
$19.57
+1,170.8%
Avg target
Bull Case
$23.80
+1,445.5%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.98
-69.1% from high
52-Week Low
$0.78
+97.5% from low
Target vs 52W High
$19.57
+293.0% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.22
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |